We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRXB.WS
1701
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$1.21M 0.01%
+123,581
New +$133K
CMMB
1702
Chemomab Therapeutics
CMMB
$10.5M
$1.21M 0.01%
+15,889
New +$1.55M
VELO
1703
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$1.21M 0.01%
+124,986
New +$1.22M
UFS
1704
DELISTED
DOMTAR CORPORATION (New)
UFS
$1.21M 0.01%
+21,964
New +$1.06M
UPS icon
1705
PUT
United Parcel Service
UPS
$89.7B
$1.21M 0.01%
5,800
+4,600
+383% +$920K
NCMI icon
1706
National CineMedia
NCMI
$371M
$1.2M 0.01%
23,754
-30,184
-56% -$1.42M
PG icon
1707
CALL
Procter & Gamble
PG
$347B
$1.2M 0.01%
8,900
+8,000
+889% +$1.08M
PRDS
1708
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.2M 0.01%
120,000
-1,440
-1% -$14.5K
OPCH icon
1709
Option Care Health
OPCH
$3.53B
$1.2M 0.01%
54,745
-508,867
-90% -$9.81M
IPVF.WS
1710
CALL
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$1.2M 0.01%
+123,446
New +$121K
ARW icon
1711
Arrow Electronics
ARW
$10.8B
$1.19M 0.01%
+10,442
New +$1.22M
RELX icon
1712
RELX
RELX
$66B
$1.19M 0.01%
+44,509
New +$1.18M
USAK
1713
DELISTED
USA Truck Inc
USAK
$1.19M 0.01%
+73,720
New +$1.2M
AMAT icon
1714
CALL
Applied Materials
AMAT
$378B
$1.18M 0.01%
+8,300
New +$1.11M
PPBI
1715
DELISTED
Pacific Premier Bancorp
PPBI
$1.17M 0.01%
+27,612
New +$1.23M
MFNC
1716
DELISTED
Mackinac Financial Corporation
MFNC
$1.17M 0.01%
+59,124
New +$1.2M
WPCA.WS
1717
CALL
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$1.17M 0.01%
+120,420
New +$136K
BTWN
1718
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$1.17M 0.01%
+115,148
New +$1.19M
KRON
1719
DELISTED
Kronos Bio
KRON
$1.16M 0.01%
+48,616
New +$1.23M
GETR.WS
1720
CALL
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.16M 0.01%
+119,992
New +$125K
GNK icon
1721
Genco Shipping & Trading
GNK
$1.11B
$1.16M 0.01%
61,309
-357,198
-85% -$5.52M
SDAC
1722
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$1.16M 0.01%
+119,470
New +$1.17M
SRTA
1723
Strata Critical Medical Inc
SRTA
$440M
$1.16M 0.01%
+110,167
New +$1.09M
DYAI icon
1724
Dyadic International
DYAI
$38.6M
$1.16M 0.01%
322,075
-31,591
-9% -$132K
EWM icon
1725
iShares MSCI Malaysia ETF
EWM
$309M
$1.15M 0.01%
+45,166
New +$1.23M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.